Share-based Payment Arrangement, Expense of Aspire Biopharma Holdings, Inc. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aspire Biopharma Holdings, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
  • Aspire Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $0.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)

Aspire Biopharma Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q/A 14 Nov 2025 2025 Q3
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q/A 14 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.